TCRT ALAUNOS THERAPEUTICS INC Management Changes 8-K Filing 2023 - Management Changes Alaunos Therapeutics, Inc. entered into a Separation and Release Agreement with its CEO Kevin S. Boyle, who will receive a one-time separation payment and continue providing advisory services to the company under a consulting agreement.Get access to all SEC 8-K filings of the ALAUNOS THERAPEUTICS INC